Mycophenolate Mofetil Powder, For Suspension
Product Images NDC 72603-751

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 72603-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Mycophenolate Fig1)

An instructional illustration showing components of the oral dispensing system for a powder for suspension medication. It depicts a bottle with a child-resistant bottle cap and bottle adapter, and a separate oral dispenser syringe labeled with a plunger and tip for measuring and administering the medication orally.*

FDA Label Image

Fig2 (Mycophenolate Fig2)

An instructional line drawing showing a person holding an oral powder suspension bottle upside down and inserting the bottle's content into a measuring device or oral syringe, demonstrating how to properly prepare or measure the mycophenolate mofetil powder for suspension.*

FDA Label Image

Package Label-principal Display Panel 200 mg/ml (225 mL Bottle) (Mycophenolate Fig3)

Label for Mycophenolate Mofetil for Oral Suspension, USP 200 mg/mL powder for suspension by NorthStar Rx LLC. The label includes dosing instructions, pharmacist dispensing guidance, storage conditions, manufacturer details, barcode, and coding area for printing expiration and lot number. The product is made in India and intended for oral use.*

FDA Label Image

Package Label-principal Display Panel (200 mg/mL (225 mL Carton Label))

Carton label for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL powder for suspension. The label includes dosing instructions, pharmacist directions, storage conditions, and manufacturer information. Manufactured for NorthStar Rx LLC and by APL Healthcare Limited in India. The package contains a 225 mL bottle with adapter and oral dispensers. NDC 72603-751-01.*

FDA Label Image

Str (Mycophenolate Str)

Chemical structure of mycophenolate mofetil, the active ingredient in MYCOPHENOLATE MOFETIL oral powder for suspension 200 mg/mL by NorthStar Rx LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.